NanoSphere Health Sciences Inc. is a nano-biotechnology company focused on delivering biologically active compounds in the U.S. and Canada. The company faces significant concerns, including a very low current ratio of 0.01, indicating liquidity issues, and a negative return on assets of -89.9%, reflecting poor operational efficiency. With a market cap of only $205.50K and a stagnant stock price, the company may struggle to attract investment. Overall, while the innovative delivery system could offer potential, the financial health raises substantial red flags.
Loading financial metrics...
Debt of $48K is 11.9x the company's cash position of $4K.
No significant opportunities identified
Based on current financial metrics
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Biotechnology companies of a similar size
Based on 2025-Q2 (June 30, 2025)